European Therapies for Atherosclerosis, Hormones, Diabe...

European Therapies for Atherosclerosis, Hormones, Diabetes, Stroke, Cancer and more

European Therapies for Atherosclerosis, Hormones, Diabetes, Stroke, Cancer and more


Many members of The Life Extension Foundation use European medications as part of their antiaging program, including "smart drugs" to enhance their cognitive function, hormones, and antiaging drugs which may help to slow the onset of aging and age-related diseases, such as atherosclerosis, stroke and diabetes.

Most of the European drugs and hormones used by life extensionists have been used safely for decades throughout the world, although some are not approved by the U.S. Food & Drug Administration (FDA). For more information, please contact our advisors at 1-800-226-2370.

What follows is a description of some of the most popular of these drugs.
The Need for European Medications

Significant benefit can be obtained from products available in the United States to prevent degenerative diseases such as atherosclerosis, stroke and diabetes, and slow aging. There are some mechanisms of aging, however, which can only be controlled by the use of therapies not yet approved by the FDA. One dangerous mechanism of aging is the chronic elevation of monoamine oxidase (MAO). Elevated MAO levels seriously damage brain cells, especially dopamine producing cells.

In each decade over age 45, we lose about 13% of our dopamine producing neurons. Once 80% of these neurons are dead, Parkinson's disease is diagnosed and there is currently no long-term therapy to reverse Parkinson's disease.

By inhibiting MAO levels now, we can prevent much of the damage to brain cells that aging causes, thereby helping to prevent diseases like Parkinson's and other forms of senile dementia.

There is one drug that has been extensively documented to specifically inhibit the elevation of monoamine oxidase B (MAO B), a particularly dangerous form of MAO to brain cells. This MAO-inhibiting drug is called deprenyl. It has been used in Europe since the 1970s to treat various forms of age-related neurological diseases. The FDA approved deprenyl in 1989 for the treatment of Parkinson's disease, but not to prevent it.

Deprenyl is sold in 5 mg tablets and capsules. Healthy people only need one to two tablets a week to help prevent premature brain cell death.

Another mechanism of aging involves the excessive production of cortisol. High levels of cortisol suppress immune function, promote atherosclerosis, and damage and kill brain cells. Cortisol has been described by antiaging doctors as one of the "death hormones" our body produces that causes premature aging. Cancer and AIDS patients have exceptionally high levels of cortisol production, causing severe immune suppression that often leads to death.

Aging causes the disruption of normal cellular metabolism that results in the progressive decline in cell energy production throughout the body.

For cells to function, they must:

1. Absorb serum glucose through the cell membrane to produce energy.
2. Synthesize proteins to perform youthful cellular functions.
3. Clear out debris so that the cell does not become clogged with lipofuscin, beta-amyloid and other waste by-products that have been linked to Alzheimer's and other age-related neurological diseases.

There are drugs used in Europe to treat a wide variety of ailments associated with reduced cellular metabolism caused by normal aging.

Two of these drugs, vinpocetine and/or Hydergine have been shown to:

improve blood supply to the brain.
increase the amount of oxygen delivered to the brain.
increase oxygen use by the brain.
enhance metabolism in brain cells.
protect the brain from damage during periods of decreased and/or insufficient oxygen supply. slow the deposit of age pigment (lipofuscin) in the brain.
prevent free radical damage in brain cells.
increase intelligence, memory, learning, and recall.
enhance the use of glucose by brain cells. increase ATP levels in the brain.
stop blood from becoming sticky.
raise the brain levels of serotonin.

Vinpocetine and hydergine provide a wide range of antiaging effects in brain and other cells that you cannot easily obtain with any other therapy.
Aminoguanidine

Aminoguanidine prevents destructive crosslinking of collagen and elastin fibers in the brains of Alzheimer's patients. Such crosslinks are also one of the major causes of brain and muscle degeneration in the elderly. Scientists have found that the primary cause of cross linking is protein glycosylation, which is the chemical reaction of blood sugar (glucose) with body proteins.

Aminoguanidine blocks and apparently prevents crosslinking due to glycosylation. Studies in animals have shown that aminoguanidine can prevent aging of the blood vessels associated with diabetes and atherosclerosis, and molecular cross-linking in the brain. Since there has only been limited clinical experience with aminoguanidine, we suggest that it be taken under the supervision of a physician.

Healthy people usually take 300 mg a day while diabetics may take 600 mg daily.
Biostim

Each biostim tablet contains 1 mg of the active ingredient which is extracted from bacteria. The product is a potent immune system stimulant that boosts all three levels of defense against infection, i.e.

1. phagocytosis
2. humoral reactions and
3. cellular immunity

Biostim, by stimulating the immune system, has been shown to protect against illness caused by bacteria, fungi, and viruses in both normal people and those with a depressed immune system. The effectiveness of a once yearly treatment with biostim has been proven in medical trials. It can be used to boost immunity and to avoid chronic infections of the lungs. Regular use of biostim means you lower the risk of infection and experience shorter periods of infection.

All Contents Copyright © 1995-2009 Life Extension Foundation® All rights reserved.